XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows From Operating Activities:    
Net income $ 70,588 $ 107,623
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 75,225 77,163
Amortization of debt issuance costs and discounts 3,078 3,130
Deferred income tax provision 17,397 26,530
Equity-based compensation 8,207 9,531
Other, including loss on sale or disposal of assets, net 13,425 8,539
Changes in assets and liabilities:    
Accounts receivable (22,415) (9,690)
Inventories (4,881) (27,126)
Prepaid expenses and other current assets (5,372) (10,101)
Accounts payable and accrued expenses 13,925 34,902
Accrued salaries, wages and benefits 2,375 (5,737)
Deferred revenue 58,256 80,778
Other accrued liabilities 12,562 4,699
Right of use assets and operating lease liabilities 197 354
Other assets and liabilities (7,666) (961)
Net cash provided by operating activities 234,901 299,634
Cash Flows From Investing Activities:    
Capital expenditures (145,587) (101,048)
Net cash used in investing activities (145,587) (101,048)
Cash Flows From Financing Activities:    
Repayments of long-term debt (6,000) (6,000)
Proceeds from draws on revolving credit facility 20,000  
Repayments of revolving credit facility (20,000)  
Purchase of treasury stock (13,947) (454,801)
Payment of tax withholdings on equity-based compensation through shares withheld (6,340) (22,067)
Exercise of stock options 1,644 1,935
Debt issuance costs   (469)
Other financing activities (245) (371)
Net cash used in financing activities (24,888) (481,773)
Change in Cash and Cash Equivalents, including Restricted Cash 64,426 (283,187)
Cash and Cash Equivalents, including Restricted Cash—Beginning of period 82,320 444,486
Cash and Cash Equivalents, including Restricted Cash—End of period 146,746 161,299
Supplemental Disclosure of Noncash Investing and Financing Activities    
Capital expenditures in accounts payable 53,080 25,599
Right-of-use assets obtained in exchange for financing lease obligations $ 1,770  
Treasury stock purchases not yet settled in other accrued liabilities   $ 9,756